BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35168603)

  • 1. Application of CRISPR/Cas9-based mutant enrichment technique to improve the clinical sensitivity of plasma EGFR testing in patients with non-small cell lung cancer.
    Kim B; Kim Y; Shin S; Lee ST; Cho JY; Lee KA
    Cancer Cell Int; 2022 Feb; 22(1):82. PubMed ID: 35168603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
    Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
    Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and quantification of
    Silveira C; Sousa AC; Janeiro A; Malveiro S; Teixeira E; Brysch E; Pantarotto M; Felizardo M; Madureira R; Nogueira F; Guimarães C; Matos C; Canário D; Bruges-Armas J; Carmo-Fonseca M
    Transl Lung Cancer Res; 2021 Mar; 10(3):1200-1208. PubMed ID: 33889502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.
    Suzawa K; Yamamoto H; Ohashi K; Hashida S; Tomida S; Kubo T; Maki Y; Soh J; Tsukuda K; Kiura K; Miyoshi S; Toyooka S
    Oncol Rep; 2017 May; 37(5):3100-3106. PubMed ID: 28405680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of ddPCR and ARMS for detecting EGFR T790M status in ctDNA from advanced NSCLC patients with acquired EGFR-TKI resistance.
    Wang W; Song Z; Zhang Y
    Cancer Med; 2017 Jan; 6(1):154-162. PubMed ID: 28000387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and validation of a novel droplet digital PCR assay for ultrasensitive detection and dynamic monitoring of EGFR mutations in peripheral blood samples of non-small-cell lung cancer patients.
    Tang C; Zhu L; Zhang L; Tan C; Peng Z; Liu B; Liu W; Hu H; Bai Y; Wang B; Lin L; Liang J; Li X; Guo Y; Liu Y
    Clin Chim Acta; 2020 Nov; 510():88-96. PubMed ID: 32645388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting short length nucleic acids localized in exosomes improves plasma
    Kim Y; Shin S; Kim B; Lee KA
    Cancer Cell Int; 2019; 19():251. PubMed ID: 31582907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex picoliter-droplet digital PCR for quantitative assessment of EGFR mutations in circulating cell-free DNA derived from advanced non-small cell lung cancer patients.
    Yu Q; Huang F; Zhang M; Ji H; Wu S; Zhao Y; Zhang C; Wu J; Wang B; Pan B; Zhang X; Guo W
    Mol Med Rep; 2017 Aug; 16(2):1157-1166. PubMed ID: 29067441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome-based detection of EGFR T790M in plasma and pleural fluid of prospectively enrolled non-small cell lung cancer patients after first-line tyrosine kinase inhibitor therapy.
    Kim Y; Shin S; Lee KA
    Cancer Cell Int; 2021 Jan; 21(1):50. PubMed ID: 33435996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of the T790M mutation of EGFR in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study).
    Takahama T; Sakai K; Takeda M; Azuma K; Hida T; Hirabayashi M; Oguri T; Tanaka H; Ebi N; Sawa T; Bessho A; Tachihara M; Akamatsu H; Bandoh S; Himeji D; Ohira T; Shimokawa M; Nakanishi Y; Nakagawa K; Nishio K
    Oncotarget; 2016 Sep; 7(36):58492-58499. PubMed ID: 27542267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five Technologies for Detecting the
    Chen YL; Lin CC; Yang SC; Chen WL; Chen JR; Hou YH; Lu CC; Chow NH; Su WC; Ho CL
    Front Oncol; 2019; 9():631. PubMed ID: 31380273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CRISPR Test for Rapidly and Sensitively Detecting Circulating EGFR Mutations.
    Tsou JH; Leng Q; Jiang F
    Diagnostics (Basel); 2020 Feb; 10(2):. PubMed ID: 32093010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Droplet Digital PCR as a Molecular Tool for the Detection of the
    Durgut S; Salihefendić L; Pećar D; Čeko I; Mulahuseinović N; Izmirlija M; Konjhodžić R
    Balkan J Med Genet; 2023 Dec; 26(2):21-26. PubMed ID: 38482255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Plasma EGFR Mutations in NSCLC Patients with a Validated ddPCR Lung cfDNA Assay.
    Guo QM; Wang L; Yu WJ; Qiao LH; Zhao MN; Hu XM; Sun YM; Ni S; Xu YH; Lou JT
    J Cancer; 2019; 10(18):4341-4349. PubMed ID: 31413754
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of PCR-HRM, RFLP, and direct sequencing as simple and cost-effective methods to detect common EGFR mutations in plasma cell-free DNA of non-small cell lung cancer patients.
    Zaini J; Syahruddin E; Yunus M; Andarini SL; Hudoyo A; Masykura N; Yasril R; Ridwanuloh A; Hidajat H; Nurwidya F; Suharsono S; Utomo ARH
    Cancer Rep (Hoboken); 2019 Aug; 2(4):e1159. PubMed ID: 32721094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of Different Therapies on EGFR Mutants by Circulating Cell-free DNA of Lung Adenocarcinoma and Prognosis].
    Su F; Zheng K; Fu Y; Wu Q; Tang Y; Wang W; Jiang L
    Zhongguo Fei Ai Za Zhi; 2018 May; 21(5):389-396. PubMed ID: 29764589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing Ultrasensitive Library-Aliquot-Based Droplet Digital PCR for Detecting T790M in Plasma-Circulating Tumor DNA of Non-small-Cell-Lung-Cancer Patients.
    Yang K; Li J; Zhao J; Ren P; Wang Z; Wei B; Dong B; Sun R; Wang X; Groen HJM; Ma J; Guo Y
    Anal Chem; 2018 Oct; 90(19):11203-11209. PubMed ID: 30156405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital PCR-Based Detection of EGFR Mutations in Paired Plasma and CSF Samples of Lung Adenocarcinoma Patients with Central Nervous System Metastases.
    Huang R; Xu X; Li D; Chen K; Zhan Q; Ge M; Zhou X; Liang X; Guan M
    Target Oncol; 2019 Jun; 14(3):343-350. PubMed ID: 31161597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR.
    Watanabe M; Kawaguchi T; Isa S; Ando M; Tamiya A; Kubo A; Saka H; Takeo S; Adachi H; Tagawa T; Kakegawa S; Yamashita M; Kataoka K; Ichinose Y; Takeuchi Y; Sakamoto K; Matsumura A; Koh Y
    Clin Cancer Res; 2015 Aug; 21(15):3552-60. PubMed ID: 25882755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The detection of primary and secondary EGFR mutations using droplet digital PCR in patients with nonsmall cell lung cancer.
    Suryavanshi M; Mehta A; Panigrahi MK; Jaipuria J; Saifi M; Jain K; Kumar D; Verma H; Sharma SK; Batra U; Dutta K; Talwar V; Doval DC
    Lung India; 2018; 35(5):384-389. PubMed ID: 30168456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.